KemPharm Inc. (NASDAQ: KMPH) stock plunged by 0.50% at last close while the KMPH stock price plunged by 3.18% in the pre-market trading session. KemPharm is a specialty pharmaceutical firm that uses its LAT (Ligand Activated Therapy) technology to identify and create proprietary prodrugs to treat significant medical problems.
KMPH stock’ Update
KemPharm has stated that research using AZSTARYS will be highlighted in a poster presentation at the 2021 Psych Congress. It will be held in San Antonio, Texas, from October 29 to November 1, 2021, both digitally and in person. The data from clinical investigations evaluating the relative bioavailability and steady-state pharmacokinetics (PK) of AZSTARYS are being discussed in this presentation.
Serdexmethylphenidate which is a KemPharm prodrug of d-methylphenidate, is co-formulated with immediate-release d-MPH in AZSTARYS. It is a once-daily medicine used to cure ADHD in patients aged six and up. AZSTARYS is being commercialized in the United States by Corium, a Gurnet Point Capital portfolio company.
Moreover,
The poster named “Steady-State Pharmacokinetics and Relative Bioavailability of Serdexmethylphenidate/d-Methylphenidate, a Treatment for Attention-Deficit/Hyperactivity Disorder, Containing a Novel Prodrug of d-Methylphenidate,” provides thorough information from two different pharmacokinetic studies. In the first research, 30 patients were given a single dose of AZSTARYS and one dose of extended-release d-MPH hydrochloride, and the quantity of d-MPH that entered systemic circulation (relative bioavailability) was examined (HCI). The findings in the poster showed that d-MPH plasma concentrations steadily increased after a single dosage of AZSTARYS (SDX/d-MPH capsules) and were stable through late-day time points.
And,
The findings from the second trial in the poster presentation showed that AZSTARYS given one time daily for four days attained steady-state d-MPH plasma levels before the third dose of AZSTARYS. Steady-state pharmacokinetics is a statistic for determining how long it takes for medication levels in the body to remain steady when given continuously.
